Your browser doesn't support javascript.
loading
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.
Ismail, Nazir Ahmed; Omar, Shaheed Vally; Moultrie, Harry; Bhyat, Zaheda; Conradie, Francesca; Enwerem, M; Ferreira, Hannetjie; Hughes, Jennifer; Joseph, Lavania; Kock, Yulene; Letsaolo, Vancy; Maartens, Gary; Meintjes, Graeme; Ngcamu, Dumisani; Okozi, Nana; Padanilam, Xavier; Reuter, Anja; Romero, Rodolf; Schaaf, Simon; Te Riele, Julian; Variava, Ebrahim; van der Meulen, Minty; Ismail, Farzana; Ndjeka, Norbert.
Afiliação
  • Ismail NA; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa; Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
  • Omar SV; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa. Electronic address: shaheedvo@nicd.ac.za.
  • Moultrie H; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Bhyat Z; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Conradie F; Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.
  • Enwerem M; Amity Health Consortium, Johannesburg, South Africa.
  • Ferreira H; Klerksdorp/Tshepong Hospital Complex, Multi-drug resistant-Extensively-drug resistant Tuberculosis Unit, North West Provincial Department of Health, Perinatal HIV Research Unit, Klerksdorp, South Africa.
  • Hughes J; Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Joseph L; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Kock Y; Drug-resistant Tuberculosis Directorate, National Department of Health, Pretoria, South Africa.
  • Letsaolo V; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Maartens G; Department of Medicine and Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Meintjes G; Department of Medicine and Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
  • Ngcamu D; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Okozi N; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Padanilam X; Department of Health, Sizwe Tropical Disease Hospital, Johannesburg, South Africa.
  • Reuter A; Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa.
  • Romero R; District Clinical Specialist Team, Namakwa, South Africa.
  • Schaaf S; Desmond Tutu Tuberculosis Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Te Riele J; Metro Tuberculosis Hospital Centre, Brooklyn Chest Hospital, Western Cape, South Africa.
  • Variava E; Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa; Klerksdorp/Tshepong Hospital Complex, Multi-drug resistant-Extensively-drug resistant Tuberculosis Unit, North West Provincial Department of Health, Perinatal HIV Research Unit, Klerksdorp, South Africa.
  • van der Meulen M; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa.
  • Ismail F; Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South Africa; Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa.
  • Ndjeka N; Drug-resistant Tuberculosis Directorate, National Department of Health, Pretoria, South Africa.
Lancet Infect Dis ; 22(4): 496-506, 2022 04.
Article em En | MEDLINE | ID: mdl-34780706
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Idioma: En Ano de publicação: 2022 Tipo de documento: Article